Health Kick: Zelira’s cannabis-derived insomnia treatment has investors dreaming
Health & Biotech
Link copied to
Stockhead’s resident Health and Biotech expert Tim Boreham is putting down the pen and picking up the microphone for another instalment of The Health Kick Podcast.
In this episode Tim chats with Dr Richard Hopkins, Managing Director of Zelira Therapeutics (ASX:ZLD).
Zelira Therapeutics (formerly Zelda) is a medicinal cannabis company focused on developing therapeutic treatments for a variety of medical conditions.
The company owns a portfolio of proprietary revenue generating products and has a pipeline of candidates undergoing clinical development.
Earlier this month, Zelira completed a $8.75M oversubscribed share placement.
Click below to hear about the company’s unique offering, progress in 2020 and plans for the year ahead.
Like to listen to podcasts through another app? Just search for The Health Kick Podcast with Tim Boreham and subscribe!